83004-13-1

Basic information

• Product Name: 2-bromo-6-ethyl-pyridine
• Synonyms: 2-bromo-6-ethyl-pyridine
• CAS NO: 83004-13-1
• Molecular Formula: C₇H₈BrN
• Molecular Weight: 186
• Mol File: 83004-13-1.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-bromo-6-ethyl-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-6-ethyl-pyridine(83004-13-1)
• EPA Substance Registry System: 2-bromo-6-ethyl-pyridine(83004-13-1)

Safety Data

• Hazardous Substances Data: 83004-13-1(Hazardous Substances Data)

Usage

General Description

2-bromo-6-ethyl-pyridine is a chemical compound with the molecular formula C7H8BrN. It is an organic compound that belongs to the pyridine class of chemicals. The "2-bromo-6-ethyl" prefix indicates the specific position of the bromine and ethyl groups on the pyridine ring. 2-bromo-6-ethyl-pyridine is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used as a building block in organic synthesis for the production of various functional groups. 2-bromo-6-ethyl-pyridine is a colorless to pale yellow liquid with a strong odor, and it is typically handled and stored under controlled conditions due to its reactivity and potential hazards.

Upstream product

• 5315-25-3 2-bromo-6-methylpyridine 
• 74-88-4 methyl iodide 
• 21717-29-3 2-amino-6-ethylpyridine 
• 109-04-6 2-bromo-pyridine 
• 74-85-1 ethene 

Downstream Products

• 59146-66-6 6-ethyl-2-cyanopyridine 
• 521917-55-5 2-Bromo-6-ethyl-pyridin-4-ylamine 
• 521917-53-3 2-bromo-6-ethyl-pyridine 1-oxide 
• 1380072-43-4 6-ethyl-2-(3-cyanophenylethynyl)pyridine 
• 1283601-75-1 bis(3,5-dimethylphenyl)(6-ethyl-2-pyridyl)phosphine 

Relevant articles and documents

IRAK4 INHIBITING AGENTS

Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.

Rare-earth-catalyzed C-H bond addition of pyridines to olefins

An efficient and general protocol for the ortho-alkylation of pyridines via C-H addition to olefins has been developed, using cationic half-sandwich rare-earth catalysts, which provides an atom-economical method for the synthesis of alkylated pyridine der

3-INDAZOLYL-4-PYRIDYLISOTHIAZOLES

The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.